Chemotherapy-Induced Peripheral Neurotoxicity as A Risk Factor for Poor Sleep Quality in Breast Cancer Survivors Treated with Docetaxel

OBJECTIVE: The purpose of this study was to explore sleep quality and to determine whether chemotherapy-induced peripheral neurotoxicity is a risk factor for poor sleep quality in breast cancer survivors who receive docetaxel treatment. METHODS: Secondary data analysis from a cross-sectional study....

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Ya-Ning, Jheng, You-Wun, Wang, Ya-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785078/
https://www.ncbi.nlm.nih.gov/pubmed/33426192
http://dx.doi.org/10.4103/apjon.apjon_51_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785078/
https://www.ncbi.nlm.nih.gov/pubmed/33426192
http://dx.doi.org/10.4103/apjon.apjon_51_20

Ejemplares similares